INS and Alzheimer disease: There is a feed-forward loop between insulin resistance and AD progression, resulting in higher levels of neuroinflammatory cytokines, reactive oxygen species, intracellular Ca2+, Aβ, GSK-3β activation, and tau hyperphosphorylation (Wei et al., 2021).